Skip to main content

Month: August 2020

Northeast Ohio Medical University Plans for Virtual Fall with Mediasite

MADISON, Wis., Aug. 20, 2020 (GLOBE NEWSWIRE) — Longtime Mediasite user Northeast Ohio Medical University (NEOMED) successfully pivoted to online during the initial spring campus shutdown. They found the perfect formula for a live hybrid fall: a rotating schedule for on-site and online students and an essential mix of Mediasite streaming live- and on-demand video lectures and Zoom collaborative calls. Medical students of the Rootstown, Ohio university will still get a front row seat to all classes, demos, simulations and campus events, regardless of where they’re learning.  “Our students and faculty were already comfortable with online learning prior to the COVID-19 shutdown last spring, because we’ve been using Mediasite for the past 15 years,” said Michael Wright, Director, Academic Technology, NEOMED. “Mediasite is at the heart...

Continue reading

Can B Corp Announces Second Quarter 2020 Results

Diversified Product Line Up Expected to Result in Return to GrowthHICKSVILLE, NY, Aug. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a diversified health and wellness company, announced today operating and financial results for the second quarter ended June 30, 2020.Management Commentary:“Like most companies, we have been negatively impacted by the global COVID-19 pandemic and the uncertainty brought on by it. We have taken necessary steps to try to stabilize our business and reduce our operating expenses,” commented Marco Alfonsi, Can B’s Chief Executive Officer.Mr. Alfonsi continued, “Our pipeline of opportunities remains strong highlighted by our exclusive license agreement with Lifeguard Licensing Corp. for the use of the well-known LifeGuard brand name and logo for...

Continue reading

Brunswick Corporation Announces Final Repayment of Revolving Credit Facility

METTAWA, Ill., Aug. 20, 2020 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) continues to strengthen its financial position with a number of recent actions that have enhanced its liquidity and financial flexibility.  After repaying $300 million of its revolving credit facility in June and July, today the Company announced that it will repay the remaining $85 million balance of this revolving line of credit on August 21.   In March, Brunswick drew down $385 million of its revolving line of credit as a precautionary action in order to increase its cash position and to enhance its liquidity and financial flexibility during a period of substantial uncertainty related to the COVID-19 pandemic. In addition, Brunswick recently received a strong endorsement of the Company’s performance and strategy when leading credit rating agencies...

Continue reading

Integra Signs Memorandum of Understanding With United States Bureau of Land Management, Provides Update on Permitting and Pre-Feasibility Level Engineering Programs, and Adds Exploration Drill Rig at War Eagle

The Company has signed a Memorandum of Understanding (the “Agreement”, or “MOU”) with the United States Bureau of Land Management (“BLM”) to facilitate the hiring of a dedicated  mineral specialist in the Marsing, Idaho BLM office that will oversee future permitting work for the DeLamar Gold-Silver Project (“DeLamar Project” or the “Project”).A number of permitting activities are currently underway at the DeLamar Project, including preliminary approval of the surface water sampling and analysis program, the groundwater well drilling plan and sampling and analysis program, as well as the preliminary approval of the proposed air monitoring program and the installation of the meteorological tower at the site.Pre-Feasibility level Metallurgical Testing: Minerology, sulfur and clay speciation testwork as well as pre-oxidation methods are being...

Continue reading

In Vitro Diagnostics Market to Reach USD 87.11 Billion by 2026; Increasing Prevalence of Cancer Will Enable Growth, says Fortune Business Insights

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — According to the report, the global In Vitro Diagnostics Market was valued at USD 61.22 Billion in 2018 is predicted to reach USD 87.11 Billion by 2026, exhibiting a CAGR of 4.5% during the forecast period.Introduction of new techniques for disease diagnosis is a key factor driving the market, states Fortune Business Insights in a report, titled “In Vitro Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019-2026.”As per the report...

Continue reading

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 millionThe Extraordinary General Meeting of Acarix AB (“Acarix” or the “Company”) resolved on 11 August 2020, subsequent to the board of directors proposal on 15 July 2020, to carry out a new share issue of a maximum of 86,156,738 shares with preferential rights for the Company’s existing shareholders at a subscription price of SEK 0.65, which may provide the Company with approximately SEK 56 million before deduction of cost related to the rights issue (the “Rights Issue”). The board of directors of Acarix has in connection with the Rights Issue, and prior to the subscription period that starts tomorrow, prepared a prospectus which today has been approved by the Swedish Financial Supervisory Authority (the “SFSA”).Publication...

Continue reading

Acarix offentliggör prospekt i samband med företrädesemission om cirka 56 MSEK

Acarix offentliggör prospekt  i samband med företrädesemission om cirka 56 MSEKExtra bolagsstämma i Acarix AB (“Acarix” eller “Bolaget”) beslutade den 11 augusti 2020, efter styrelsens förslag den 15 juli 2020, om en nyemission av högst 86 156 738 aktier med företrädesrätt för befintliga aktieägare till en teckningskurs om 0,65 SEK, som högst kan tillföra Bolaget cirka 56 MSEK före avdrag för kostnader relaterade till transaktionen (“Företrädesemissionen”). Styrelsen i Acarix har med anledning av Företrädesemissionen, och inför teckningsperioden som inleds imorgon 21 augusti 2020, upprättat ett prospekt som idag har godkänts av Finansinspektionen.Offentliggörande av prospektetFör fullständig information om Företrädesemissionen hänvisas till det prospekt som upprättats av Bolaget och idag har godkänts...

Continue reading

Correction: IMCD Bolsters Brazil Speciality Distribution Strategy by Acquiring VitaQualy Comércio de Ingredientes

** Disclaimer: The previous release had an error in the third paragraph. The word “Samba” should be replaced with “VitaQualy”. Below, the correct pdf.ROTTERDAM, The Netherlands (19 August 2020) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announced it has acquired 100% of the outstanding shares of Brazilian speciality ingredient distributor, VitaQualy Comércio de Ingredientes LTDA (“VitaQualy”).“The acquisition of VitaQualy aligns with our company’s global Food & Nutrition strategy to offer trend-based solutions and the distribution of speciality ingredients around four main pillars – taste, texture, nutrition, and function,” said Nicolas Kaufmann, Managing Director, IMCD Brasil. “As a reputable distributor of flavors and ingredients, VitaQualy strengthens...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.